Supada R. Rojatkar
- Pharmacology top 2%
- Ginger and Zingiberaceae research 6
- Pharmacological Effects of Natural Compounds 5
- Drug Discovery top 5%
- Food Science top 5%
- Essential Oils and Antimicrobial Activity 8
- Biochemistry top 10%
-
- Sesquiterpenes and Asteraceae Studies 19
-
- Natural product bioactivities and synthesis 12
- Plant Toxicity and Pharmacological Properties 9
-
- Phytochemistry and Biological Activities 12
-
- Marine Sponges and Natural Products 5
- Co-authors
- Subhash L. BodhankarBhimsen A. NagasampagiAmit D. KandhareAnand A. ZanwarVijay M. KhedkarVarsha ShriramPrashant K. DhakephalkarC. Latha
- Partner nations
- IndiaUnited States
In The Last Decade
Supada R. Rojatkar
52 papers receiving 821 citations
Peers
Comparison fields: 5 of 103
- Pharmacology 222
- Drug Discovery 3
- Complementary and alternative medicine 108
- Food Science 181
- Biochemistry 48
Countries citing papers authored by Supada R. Rojatkar
This map shows the geographic impact of Supada R. Rojatkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supada R. Rojatkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supada R. Rojatkar more than expected).
Fields of papers citing papers by Supada R. Rojatkar
This network shows the impact of papers produced by Supada R. Rojatkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supada R. Rojatkar. The network helps show where Supada R. Rojatkar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Supada R. Rojatkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 8 | |
| 4 | 2019 | 7 | |
| 5 | 2019 | 3 | |
| 6 | 2018 | 24 | |
| 7 | 2017 | 34 | |
| 8 | 2016 | 96 | |
| 9 | Spectral characterization, docking and in-vivo anti-inflammatoryactivity of Isoivangustin, a constituent isolated from methanolextract of Cyathocline purpurea | 2015 | 2 |
| 10 | Development and validation of HPTLC method for quantitative analysis of 24-methylcycloartenol ferulic acid extracted from rice bran | 2014 | 1 |
| 11 | 2014 | 67 | |
| 12 | 2014 | 20 | |
| 13 | Antibacterial & antiplasmid activities of Helicteres isora L. | 2010 | 17 |
| 14 | 2009 | 53 | |
| 15 | 2008 | 77 | |
| 16 | 2008 | 7 | |
| 17 | Isolation of new straight chain compounds from Acacia nilotica | 2006 | 3 |
| 18 | 2006 | 59 | |
| 19 | 2000 | 13 | |
| 20 | 1987 | 3 |
About Supada R. Rojatkar
Supada R. Rojatkar is a scholar working on Cancer Research, Pharmacology and Toxicology, having authored 54 papers that have together received 882 indexed citations. Recurring topics across this work include Sesquiterpenes and Asteraceae Studies (19 papers), Natural product bioactivities and synthesis (12 papers), Phytochemistry and Biological Activities (12 papers), Plant Toxicity and Pharmacological Properties (9 papers), Essential Oils and Antimicrobial Activity (8 papers), Ginger and Zingiberaceae research (6 papers), Marine Sponges and Natural Products (5 papers) and Pharmacological Effects of Natural Compounds (5 papers). The work is most often cited by research in Pharmacology (222 citations), Drug Discovery (3 citations) and Complementary and alternative medicine (108 citations). Supada R. Rojatkar has collaborated with scholars based in India and United States. Frequent co-authors include Subhash L. Bodhankar, Bhimsen A. Nagasampagi, Amit D. Kandhare, Anand A. Zanwar, Vijay M. Khedkar, Varsha Shriram, Prashant K. Dhakephalkar, C. Latha, Vedavati G. Puranik and Dhiman Sarkar.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.